表紙
市場調査レポート

大腸癌治療 - パイプライン製品の分析

Colorectal Cancer - Pipeline Review, 2015

発行 GlobalData 商品コード 344263
出版日 ページ情報 英文 258 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
大腸癌治療 - パイプライン製品の分析 Colorectal Cancer - Pipeline Review, 2015
出版日: 2015年10月01日 ページ情報: 英文 258 Pages
概要

当レポートでは、大腸癌治療のパイプライン製品について調査分析し、主要なパイプライン製品、主要企業、開発段階別のパイプライン製品、主な臨床試験データ、最近の動向について、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 大腸癌治療の概要

第3章 開発中の製品

  • 大腸癌治療 - パイプライン製品:開発段階別
  • 大腸癌治療 - パイプライン製品:地域別
  • 大腸癌治療 - パイプライン製品:規制経路別
  • 大腸癌治療 - パイプライン製品:承認時期別 (予定)
  • 大腸癌治療 - 進行中の臨床試験

第4章 大腸癌治療:開発中のパイプライン製品 (企業別)

  • 大腸癌治療企業 - パイプライン製品:開発段階別
  • 大腸癌治療 - パイプライン製品:開発段階別

第5章 企業と製品の概要

  • A2K Technologies
  • Abbott Diagnostics
  • Advanced Marker Discovery, S.L.
  • Advpharma Inc.
  • Ambergen, Inc.
  • Ambrilia Biopharma Inc.
  • Applied Proteomics, Inc.
  • Arizona State University
  • ArtemixRx
  • Asuragen, Inc.
  • Bio Mark Ltd
  • Biocartis SA
  • Biodesix Inc.
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMark Technologies Inc.
  • BioMarker Strategies, LLC
  • bioMerieux S.A.
  • Biomoda, Inc. (休止中)
  • Biosceptre (Aust) Pty Ltd
  • BioSystems International
  • Biotechnostics GmbH
  • Biotron Limited
  • Castle Biosciences Incorporated
  • Cellmid Limited
  • Ceres Nanosciences, Inc.
  • Cernostics Inc.
  • ChemImage Corporation
  • China Sky One Medical, Inc.
  • Chinese University of Hong Kong
  • Chronix Biomedical, Inc.
  • Cleveland Diagnostics Inc.
  • ColoPrev
  • Columbia University
  • Courtagen Life Sciences, Inc.
  • CS-Keys, Inc.
  • Dartmouth College
  • Di.V.A.L Toscana srl
  • diaDexus, Inc.
  • DiagnoCure Inc.
  • Diaxonhit S.A.
  • EDP Biotech Corporation
  • Epigenomics AG
  • Eureka Genomics Corporation
  • Eventus Diagnostics, Inc.
  • Exact Sciences Corporation
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fina Biotech
  • GenomicTree, Inc. など

第6章 大腸癌治療:最近の動向

第7章 付録

図表

目次
Product Code: GDME0082EPD

GlobalData's Medical Devices sector report, "Colorectal Cancer - Pipeline Review, 2015" provides an overview of Colorectal Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Colorectal Cancer Overview

3. Products under Development

  • 3.1. Colorectal Cancer - Pipeline Products by Stage of Development
  • 3.2. Colorectal Cancer - Pipeline Products by Territory
  • 3.3. Colorectal Cancer - Pipeline Products by Regulatory Path
  • 3.4. Colorectal Cancer - Pipeline Products by Estimated Approval Date
  • 3.5. Colorectal Cancer - Ongoing Clinical Trials

4. Colorectal Cancer - Pipeline Products under Development by Companies

  • 4.1. Colorectal Cancer Companies - Pipeline Products by Stage of Development
  • 4.2. Colorectal Cancer - Pipeline Products by Stage of Development

5. Colorectal Cancer Companies and Product Overview

  • 5.1. A2K Technologies Company Overview
  • 5.2. Abbott Diagnostics Company Overview
  • 5.3. Advanced Marker Discovery, S.L. Company Overview
  • 5.4. Advpharma Inc. Company Overview
  • 5.5. Ambergen, Inc. Company Overview
  • 5.6. Ambrilia Biopharma Inc. Company Overview
  • 5.7. Applied Proteomics, Inc. Company Overview
  • 5.8. Arizona State University Company Overview
  • 5.9. ArtemixRx Company Overview
  • 5.10. Asuragen, Inc. Company Overview
  • 5.11. Bio Mark Ltd Company Overview
  • 5.12. Biocartis SA Company Overview
  • 5.13. Biodesix Inc. Company Overview
  • 5.14. BioMarCare Technologies Ltd. Company Overview
  • 5.15. BioMark Diagnostics Inc. Company Overview
  • 5.16. BioMark Technologies Inc. Company Overview
  • 5.17. BioMarker Strategies, LLC Company Overview
  • 5.18. bioMerieux S.A. Company Overview
  • 5.19. Biomoda, Inc. (Inactive) Company Overview
  • 5.20. Biosceptre (Aust) Pty Ltd Company Overview
  • 5.21. BioSystems International Company Overview
  • 5.22. Biotechnostics GmbH Company Overview
  • 5.23. Biotron Limited Company Overview
  • 5.24. Castle Biosciences Incorporated Company Overview
  • 5.25. Cellmid Limited Company Overview
  • 5.26. Ceres Nanosciences, Inc. Company Overview
  • 5.27. Cernostics Inc. Company Overview
  • 5.28. ChemImage Corporation Company Overview
  • 5.29. China Sky One Medical, Inc. Company Overview
  • 5.30. Chinese University of Hong Kong Company Overview
  • 5.31. Chronix Biomedical, Inc. Company Overview
  • 5.32. Cleveland Diagnostics Inc. Company Overview
  • 5.33. ColoPrev Company Overview
  • 5.34. Columbia University Company Overview
  • 5.35. Courtagen Life Sciences, Inc. Company Overview
  • 5.36. CS-Keys, Inc. Company Overview
  • 5.37. Dartmouth College Company Overview
  • 5.38. Di.V.A.L Toscana srl Company Overview
  • 5.39. diaDexus, Inc. Company Overview
  • 5.40. DiagnoCure Inc. Company Overview
  • 5.41. Diaxonhit S.A. Company Overview
  • 5.42. EDP Biotech Corporation Company Overview
  • 5.43. Epigenomics AG Company Overview
  • 5.44. Eureka Genomics Corporation Company Overview
  • 5.45. Eventus Diagnostics, Inc. Company Overview
  • 5.46. Exact Sciences Corporation Company Overview
  • 5.47. Exiqon A/S Company Overview
  • 5.48. Exosomics Siena SpA Company Overview
  • 5.49. Fina Biotech Company Overview
  • 5.50. GenomicTree, Inc. Company Overview
  • 5.51. Ghent University Company Overview
  • 5.52. GlycoZym Company Overview
  • 5.53. Health Discovery Corporation Company Overview
  • 5.54. Human Metabolome Technologies, Inc. Company Overview
  • 5.55. Ikonisys, Inc. Company Overview
  • 5.56. Innovative Health Diagnostics Company Overview
  • 5.57. IntegraGen SA Company Overview
  • 5.58. InterGenetics Incorporated Company Overview
  • 5.59. IV Diagnostics, Inc. Company Overview
  • 5.60. Lab21 Limited Company Overview
  • 5.61. Laboratorios Alpha San Ignacio Pharma S.L. Company Overview
  • 5.62. LX Diagnostics Company Overview
  • 5.63. MabCure Inc. Company Overview
  • 5.64. Matrix-Bio, Inc. Company Overview
  • 5.65. Mayo Clinic Company Overview
  • 5.66. MDxHealth SA Company Overview
  • 5.67. Metabiomics Corporation Company Overview
  • 5.68. Metabolomic Technologies Inc. Company Overview
  • 5.69. Metabolon, Inc. Company Overview
  • 5.70. MetaStat, Inc. Company Overview
  • 5.71. Milagen, Inc. Company Overview
  • 5.72. Miraculins Inc. Company Overview
  • 5.73. Mode Dx Ltd. Company Overview
  • 5.74. Myriad Genetics, Inc. Company Overview
  • 5.75. Nanosphere, Inc. Company Overview
  • 5.76. Neogenix Oncology, Inc. Company Overview
  • 5.77. NetScientific Plc Company Overview
  • 5.78. Norda ASA Company Overview
  • 5.79. Novel Bio-spectrum Technologies, Inc. Company Overview
  • 5.80. Nuclea Biotechnologies Inc. Company Overview
  • 5.81. Nuvera Biosciences, Inc. Company Overview
  • 5.82. OncoVista Innovative Therapies, Inc. Company Overview
  • 5.83. On-Q-ity, Inc. (Inactive) Company Overview
  • 5.84. Origin Sciences Limited Company Overview
  • 5.85. Orion Genomics LLC Company Overview
  • 5.86. OTraces Inc. Company Overview
  • 5.87. Oxford Cancer Biomarkers Company Overview
  • 5.88. Oxford Gene Technology Limited Company Overview
  • 5.89. Pacific Edge Limited Company Overview
  • 5.90. Panacea Pharmaceuticals, Inc. Company Overview
  • 5.91. PleX Diagnostics Company Overview
  • 5.92. Prediction Sciences Company Overview
  • 5.93. Protagen AG Company Overview
  • 5.94. Rosetta Genomics, Ltd. Company Overview
  • 5.95. Scienion AG Company Overview
  • 5.96. Seegene, Inc. Company Overview
  • 5.97. Shuwen Biotech Co. Ltd. Company Overview
  • 5.98. Siamab Therapeutics, Inc. Company Overview
  • 5.99. Sienna Cancer Diagnostics Ltd Company Overview
  • 5.100. Skuldtech France Company Overview
  • 5.101. Sysmex Corporation Company Overview
  • 5.102. Tel Aviv University Company Overview
  • 5.103. Texas A&M University Company Overview
  • 5.104. The Johns Hopkins University Company Overview
  • 5.105. TheraDiag SA Company Overview
  • 5.106. Todos Medical Company Overview
  • 5.107. Universite De Lyon Company Overview
  • 5.108. University of Alabama at Birmingham Company Overview
  • 5.109. University of Chicago Company Overview
  • 5.110. University of Texas at Austin Company Overview
  • 5.111. US Biomarkers, Inc. Company Overview
  • 5.112. Vanderbilt University Company Overview
  • 5.113. Vermillion, Inc. Company Overview
  • 5.114. Viomics Inc. Company Overview
  • 5.115. Vitatex Inc. Company Overview
  • 5.116. VolitionRX Ltd. Company Overview
  • 5.117. XEPTAGEN SpA Company Overview

6. Colorectal Cancer- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Colorectal Cancer - Pipeline Products by Stage of Development
  • Table 2: Colorectal Cancer - Pipeline Products by Territory
  • Table 3: Colorectal Cancer - Pipeline Products by Regulatory Path
  • Table 4: Colorectal Cancer - Pipeline Products by Estimated Approval Date
  • Table 5: Colorectal Cancer - Ongoing Clinical Trials
  • Table 6: Colorectal Cancer Companies - Pipeline Products by Stage of Development
  • Table 7: Colorectal Cancer - Pipeline Products by Stage of Development
  • Table 8: A2K Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Colospec - Product Status
  • Table 10: Colospec - Product Description
  • Table 11: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: AKT Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • Table 13: AKT Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • Table 14: cMET Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • Table 15: cMET Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • Table 16: PIK3CA Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • Table 17: PIK3CA Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • Table 18: PTEN Companion Diagnostic Assay - Colorectal Cancer - Product Status
  • Table 19: PTEN Companion Diagnostic Assay - Colorectal Cancer - Product Description
  • Table 20: RealTime mS9 Colorectal Cancer Test - Product Status
  • Table 21: RealTime mS9 Colorectal Cancer Test - Product Description
  • Table 22: Advanced Marker Discovery, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Screening Test - Colon Cancer - Product Status
  • Table 24: Screening Test - Colon Cancer - Product Description
  • Table 25: Advpharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Molecular Diagnostic Biomarker - Colorectal Cancer - Product Status
  • Table 27: Molecular Diagnostic Biomarker - Colorectal Cancer - Product Description
  • Table 28: Ambergen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Veracode - Colorectal Cancer - Product Status
  • Table 30: Veracode - Colorectal Cancer - Product Description
  • Table 31: Ambrilia Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Colopath/ColorectAlert - Product Status
  • Table 33: Colopath/ColorectAlert - Product Description
  • Table 34: Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: API Diagnostic Test - Colorectal Cancer - Product Status
  • Table 36: API Diagnostic Test - Colorectal Cancer - Product Description
  • Table 37: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Biomarker Test - Colorectal Cancer - Product Status
  • Table 39: Biomarker Test - Colorectal Cancer - Product Description
  • Table 40: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: ArtemixRx Prognostic Test - Colon Cancer - Product Status
  • Table 42: ArtemixRx Prognostic Test - Colon Cancer - Product Description
  • Table 43: Asuragen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Molecular Diagnostic Assay - Colon Cancer - Product Status
  • Table 45: Molecular Diagnostic Assay - Colon Cancer - Product Description
  • Table 46: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Diagnostic Test - Colorectal Adenoma - Product Status
  • Table 48: Diagnostic Test - Colorectal Adenoma - Product Description
  • Table 49: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: MSI-Biomarker Diagnostic Test - Colorectal Cancer - Product Status
  • Table 51: MSI-Biomarker Diagnostic Test - Colorectal Cancer - Product Description
  • Table 52: Biodesix Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: VeriStrat - Colorectal Cancer - Product Status
  • Table 54: VeriStrat - Colorectal Cancer - Product Description
  • Table 55: BioMarCare Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Colon MarCarePlex - Product Status
  • Table 57: Colon MarCarePlex - Product Description
  • Table 58: mCRC-Strat - Product Status
  • Table 59: mCRC-Strat - Product Description
  • Table 60: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Metabolomics-based Diagnostic Assay - Colon Cancer - Product Status
  • Table 62: Metabolomics-based Diagnostic Assay - Colon Cancer - Product Description
  • Table 63: BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Biomarker Assay - Colorectal Cancer - Product Status
  • Table 65: Biomarker Assay - Colorectal Cancer - Product Description
  • Table 66: BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Ex Vivo Biomarker Test - Colon Cancer - Product Status
  • Table 68: Ex Vivo Biomarker Test - Colon Cancer - Product Description
  • Table 69: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Diagnostic Test - Colorectal Cancer - Product Status
  • Table 71: Diagnostic Test - Colorectal Cancer - Product Description
  • Table 72: Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: CyPath Diagnostic Assay - Colorectal Cancer - Product Status
  • Table 74: CyPath Diagnostic Assay - Colorectal Cancer - Product Description
  • Table 75: Biosceptre (Aust) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Colorectal Cancer IHC Diagnostic Test - Product Status
  • Table 77: Colorectal Cancer IHC Diagnostic Test - Product Description
  • Table 78: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Diagnostic Test - Colon Cancer - Product Status
  • Table 80: Diagnostic Test - Colon Cancer - Product Description
  • Table 81: Biotechnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Diagnostic Test - Colorectal Cancer - Product Status
  • Table 83: Diagnostic Test - Colorectal Cancer - Product Description
  • Table 84: Biotron Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: C-Test - Colorectal Cancer - Product Status
  • Table 86: C-Test - Colorectal Cancer - Product Description
  • Table 87: Castle Biosciences Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: DecisionDx- Rectal Cancer - Product Status
  • Table 89: DecisionDx- Rectal Cancer - Product Description
  • Table 90: Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: MK-ELISA Assay - Colorectal Cancer - Product Status
  • Table 92: MK-ELISA Assay - Colorectal Cancer - Product Description
  • Table 93: MK-ELISA Assay - Metastatic Colorectal Cancer - Product Status
  • Table 94: MK-ELISA Assay - Metastatic Colorectal Cancer - Product Description
  • Table 95: Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 96: Nanotrap Colon Cancer Biomarker Test - Product Status
  • Table 97: Nanotrap Colon Cancer Biomarker Test - Product Description
  • Table 98: Cernostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 99: TissueCypher Colon Cancer Test - Product Status
  • Table 100: TissueCypher Colon Cancer Test - Product Description
  • Table 101: ChemImage Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: RACC Test - Colorectal Cancer - Product Status
  • Table 103: RACC Test - Colorectal Cancer - Product Description
  • Table 104: China Sky One Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Diagnostic Kit - Rectum Cancer - Product Status
  • Table 106: Diagnostic Kit - Rectum Cancer - Product Description
  • Table 107: Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
  • Table 108: Biomarker Test - Colorectal Cancer - Product Status
  • Table 109: Biomarker Test - Colorectal Cancer - Product Description
  • Table 110: Micro-RNA Based Biomarker Assay - Colon Cancer - Product Status
  • Table 111: Micro-RNA Based Biomarker Assay - Colon Cancer - Product Description
  • Table 112: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Companion Diagnostic Test - Colorectal Cancer - Product Status
  • Table 114: Companion Diagnostic Test - Colorectal Cancer - Product Description
  • Table 115: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Blood-Based Diagnostic Test - Colon Cancer - Product Status
  • Table 117: Blood-Based Diagnostic Test - Colon Cancer - Product Description
  • Table 118: ColoPrev Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: Blood-Based Diagnostic Test - Colorectal Cancer - Product Status
  • Table 120: Blood-Based Diagnostic Test - Colorectal Cancer - Product Description
  • Table 121: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 122: IGFBP-3 Diagnostic Test - Product Status
  • Table 123: IGFBP-3 Diagnostic Test - Product Description
  • Table 124: Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 125: Colorectal Cancer Diagnostic Panel - Product Status
  • Table 126: Colorectal Cancer Diagnostic Panel - Product Description
  • Table 127: CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Colorectal Cancer - Pipeline Products by Stage of Development
  • Figure 2: Colorectal Cancer - Pipeline Products by Territory
  • Figure 3: Colorectal Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Colorectal Cancer - Pipeline Products by Estimated Approval Date
  • Figure 5: Colorectal Cancer - Ongoing Clinical Trials
Back to Top